Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of skin conditions
3.2.1.2 Increasing awareness towards timely treatment of skin issues
3.2.1.3 Availability of new and efficient active ingredients to combine with triamcinolone
3.2.1.4 Growth in regulatory approval of new and advanced triamcinolone formulations
3.2.2 Industry pitfalls & challenges
3.2.2.1 Environmental concerns related to chlorofluorocarbon-based triamcinolone ointments
3.2.2.2 Presence of strong generic substitutes
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Cream
5.3 Injections
5.4 Inhalers
5.5 Other types
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Eczema
6.3 Dermatitis
6.4 Allergies
6.5 Psoriasis
6.6 Other applications
Chapter 7 Market Estimates and Forecast, By End-User, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Drug stores
7.3 Hospitals
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Alembic Pharmaceuticals Ltd.
9.2 Alkem Laboratories Ltd.
9.3 Bausch + Lomb Corporation
9.4 Coral Drugs Pvt. Ltd.
9.5 Crown Laboratories, Inc.
9.6 G&W Laboratories, Inc.
9.7 Lupin Ltd.
9.8 Perrigo Company plc
9.9 Sandoz AG
9.10 Sanofi
9.11 Taro Pharmaceutical Industries Ltd.
9.12 Teligent Pharma, Inc.
9.13 Teva Pharmaceutical Industries Ltd.
9.14 WEEFSEL PHARMA
9.15 Zydus Group
